Codex Genetics

Codex Genetics was incorporated in 2013 Q1 by scientists specialized in genomics and bioinformatics. Through the use of next generation sequencing, Codex has developed a cancer genetics test using latest seqeuncing technology - GENESIS. Together with our actively growing pharmacogenomics database, we provide valuable insights into the specific causes of each individual tumor, enabling clinicians to personalize treatment for cancer patients during routine oncology practice.